Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa

Eugenio Maiorano, Gianfranco Favia, Patrick Maisonneuve, Giuseppe Viale

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

To evaluate the clinical significance of the expression of epidermal growth factor receptor (EGFr) in oral squamous cell carcinoma (SCC), 100 formalin-fixed, paraffin-embedded cases of this tumour and ten samples of normal oral mucosa were immunostained with a monoclonal anti-EGFr antibody using an immunoalkaline phosphatase (APAAP) technique. EGFr immunoreactivity was detected in 36 of 100 tumours and in all samples of normal mucosa. Tumour cells demonstrated distinct membrane staining in 14 cases and predominantly cytoplasmic staining in 22 additional cases. EGFr was exclusively localized on the cell membrane of normal epithelial cells. Kaplan-Meyer survival curves and Cox proportional hazard regression models were used to assess overall survival and disease-free survival. A significant positive correlation was shown between EGFr membranous immunoreactivity and prolonged survival, in both univariate and multivariate analyses. Accordingly, patients with oral SCC showing down-regulated expression of membranous EGFr, who are more likely to suffer recurrence and death, should be strictly followed up and possibly treated with more aggressive therapeutic regimens.

Original languageEnglish
Pages (from-to)167-174
Number of pages8
JournalJournal of Pathology
Volume185
Issue number2
DOIs
Publication statusPublished - Jun 1998

Fingerprint

Mouth Mucosa
Epidermal Growth Factor Receptor
Squamous Cell Carcinoma
Survival
Staining and Labeling
Neoplasms
Phosphoric Monoester Hydrolases
Proportional Hazards Models
Paraffin
Formaldehyde
Disease-Free Survival
Mucous Membrane
Multivariate Analysis
Epithelial Cells
Cell Membrane
Recurrence
Membranes
Antibodies

Keywords

  • Epidermal growth factor receptor
  • Immunohistochemistry
  • Neoplasm
  • Oral mucosa
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. / Maiorano, Eugenio; Favia, Gianfranco; Maisonneuve, Patrick; Viale, Giuseppe.

In: Journal of Pathology, Vol. 185, No. 2, 06.1998, p. 167-174.

Research output: Contribution to journalArticle

@article{b31196918edd4886aad55e446c4c82bd,
title = "Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa",
abstract = "To evaluate the clinical significance of the expression of epidermal growth factor receptor (EGFr) in oral squamous cell carcinoma (SCC), 100 formalin-fixed, paraffin-embedded cases of this tumour and ten samples of normal oral mucosa were immunostained with a monoclonal anti-EGFr antibody using an immunoalkaline phosphatase (APAAP) technique. EGFr immunoreactivity was detected in 36 of 100 tumours and in all samples of normal mucosa. Tumour cells demonstrated distinct membrane staining in 14 cases and predominantly cytoplasmic staining in 22 additional cases. EGFr was exclusively localized on the cell membrane of normal epithelial cells. Kaplan-Meyer survival curves and Cox proportional hazard regression models were used to assess overall survival and disease-free survival. A significant positive correlation was shown between EGFr membranous immunoreactivity and prolonged survival, in both univariate and multivariate analyses. Accordingly, patients with oral SCC showing down-regulated expression of membranous EGFr, who are more likely to suffer recurrence and death, should be strictly followed up and possibly treated with more aggressive therapeutic regimens.",
keywords = "Epidermal growth factor receptor, Immunohistochemistry, Neoplasm, Oral mucosa, Squamous cell carcinoma",
author = "Eugenio Maiorano and Gianfranco Favia and Patrick Maisonneuve and Giuseppe Viale",
year = "1998",
month = "6",
doi = "10.1002/(SICI)1096-9896(199806)185:2<167::AID-PATH70>3.0.CO;2-E",
language = "English",
volume = "185",
pages = "167--174",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa

AU - Maiorano, Eugenio

AU - Favia, Gianfranco

AU - Maisonneuve, Patrick

AU - Viale, Giuseppe

PY - 1998/6

Y1 - 1998/6

N2 - To evaluate the clinical significance of the expression of epidermal growth factor receptor (EGFr) in oral squamous cell carcinoma (SCC), 100 formalin-fixed, paraffin-embedded cases of this tumour and ten samples of normal oral mucosa were immunostained with a monoclonal anti-EGFr antibody using an immunoalkaline phosphatase (APAAP) technique. EGFr immunoreactivity was detected in 36 of 100 tumours and in all samples of normal mucosa. Tumour cells demonstrated distinct membrane staining in 14 cases and predominantly cytoplasmic staining in 22 additional cases. EGFr was exclusively localized on the cell membrane of normal epithelial cells. Kaplan-Meyer survival curves and Cox proportional hazard regression models were used to assess overall survival and disease-free survival. A significant positive correlation was shown between EGFr membranous immunoreactivity and prolonged survival, in both univariate and multivariate analyses. Accordingly, patients with oral SCC showing down-regulated expression of membranous EGFr, who are more likely to suffer recurrence and death, should be strictly followed up and possibly treated with more aggressive therapeutic regimens.

AB - To evaluate the clinical significance of the expression of epidermal growth factor receptor (EGFr) in oral squamous cell carcinoma (SCC), 100 formalin-fixed, paraffin-embedded cases of this tumour and ten samples of normal oral mucosa were immunostained with a monoclonal anti-EGFr antibody using an immunoalkaline phosphatase (APAAP) technique. EGFr immunoreactivity was detected in 36 of 100 tumours and in all samples of normal mucosa. Tumour cells demonstrated distinct membrane staining in 14 cases and predominantly cytoplasmic staining in 22 additional cases. EGFr was exclusively localized on the cell membrane of normal epithelial cells. Kaplan-Meyer survival curves and Cox proportional hazard regression models were used to assess overall survival and disease-free survival. A significant positive correlation was shown between EGFr membranous immunoreactivity and prolonged survival, in both univariate and multivariate analyses. Accordingly, patients with oral SCC showing down-regulated expression of membranous EGFr, who are more likely to suffer recurrence and death, should be strictly followed up and possibly treated with more aggressive therapeutic regimens.

KW - Epidermal growth factor receptor

KW - Immunohistochemistry

KW - Neoplasm

KW - Oral mucosa

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0031866671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031866671&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199806)185:2<167::AID-PATH70>3.0.CO;2-E

DO - 10.1002/(SICI)1096-9896(199806)185:2<167::AID-PATH70>3.0.CO;2-E

M3 - Article

C2 - 9713343

AN - SCOPUS:0031866671

VL - 185

SP - 167

EP - 174

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -